Creative Biolabs Develops Versatile Bispecific Antibodies for Different Applications
As a prominent antibody manufacturer, Creative Biolabs equipped with a knowledgeable team now is capable of developing versatile bispecific antibodies for different BsAb applications, including but not limited to oncology, immunology, hematology, ophthalmology, osteology, pulmonary and respiratory diseases.
June 30, 2019 /MarketersMedia/ —
As a prominent antibody manufacturer, Creative Biolabs equipped with a knowledgeable team now is capable of developing versatile bispecific antibodies for different BsAb applications, including but not limited to oncology, immunology, hematology, ophthalmology, osteology, pulmonary and respiratory diseases.
Owing to its unique artificially designed structures that enable simultaneously identify two or more different antigens, bispecific antibody has gradually become a rising star in the field of cancer and other diseases treatment.
In Creative Biolabs, scientists engineer BsAbs for the application of oncology by interfering with signaling pathways involved in tumor development, or redirecting cytotoxic immune cells, such as T cells and NK cells to kill tumors, or delivering radioactive therapeutics to tumor cells. BiTE, Triomab, DART, TandAb, and Tandem scFv-Fc BsAb are common BsAb formats for this purpose offered in Creative Biolabs. BsAbs that interfere with two (or more) receptors or ligands in these pathways simultaneously can block a signaling pathway and its backup pathway, or block one pathway at two points. In oncology, payload delivery mediated by BsAbs is characterized by higher sensitivity and specificity in imaging in radioimmunodetection, bringing promising therapeutic effects in pretargeting radioimmunotherapy.
Bispecific antibodies also retain enormous influences for the treatment of various immunological disorders in the immunology filed, including chronic inflammation, autoimmune disease, hypersensitivity, immune deficiency, and transplant rejection. Symptom and the progression of the disease can be controlled since BsAb reduces the possibility of escaping mechanisms and increases drug efficacy.
“For the sake of increasing requirements in BsAbs filed, our team have accumulated years of hands-on experience and succeeded in the establishment of a comprehensive one-stop BsAb development services, covering bispecific antibodies engineering, analysis and manufacturing. And our platform can customize a unique bispecific antibody in terms of clients’ different needs, which can greatly save the time and cost with a fast turnaround time”, said the manager in Creative Biolabs.
The BsAbs have been reportedly applied in plenty of fields. More detailed information can be reached at https://www.creative-biolabs.com/bsab.
About
Creative Biolabs was established in 2004 by scientists who are dedicated to conquering of cancer. Over the past 10 years, Creative Biolabs has grown into a recognized world leader in antibody discovery, engineering, production, and analysis. Standing on the shoulder of a giant, the bispecific antibody (BsAb) team has a collective of experienced scientists committed to providing high-quality services to customers all over the world. Now, with the cutting-edge platforms and methods (quadroma development, chemical conjugation, and genetic engineering), a comprehensive list of bispecific antibody products is available to customers in academia and industry fields.
Contact Info:
Name: Candy Swift
Email: Send Email
Organization: Creative Biolabs Inc.
Website: https://www.creative-biolabs.com/bsab
Source: MarketersMedia
Release ID: 88891287
Copyright © 1999-2013 SproutNews.com
